Medpace Holdings, Inc.
NASDAQ:MEDPMedical - Diagnostics & Research
-$4.51 today
- Market cap
- $18.09B
- Beta
- 1.18
- P/E (TTM)
- 28.2
- EPS (TTM)
- $16.19
Volume 0.21M
Average 0.36M
MEDP Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Medpace Holdings, Inc.NASDAQ: MEDP
Accumulated OCI · Q3 FY2026 · quarter ended Sep 2026
Accumulated OCI remains negative
Q3 FY2026 Accumulated OCI was -$7.9M, compared with -$5.65M a year earlier.
Context
- Accumulated OCI amounted to 0.3% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
- Accumulated OCI grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -39.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (4.91M) USD
- Year-over-year change
- +66.7%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.91M) | +66.7% |
| FY2024 | 2024-12-31 | (14.74M) | -46.4% |
| FY2023 | 2023-12-31 | (10.07M) | +18.7% |
| FY2022 | 2022-12-31 | (12.39M) | -155.7% |
| FY2021 | 2021-12-31 | (4.85M) | — |
Accumulated OCI vs competitors
How MEDP compares with its peers on the latest reported figures
- MEDP's Sep 2026 Accumulated OCI of -$7.9M is the highest of the 5 companies compared; the peer median is -$196.24M.
- Its year-over-year change of -39.8% is the 4th highest of 5, against a peer median of -22.0%.
- Accumulated OCI amounts to 0.3% of total assets for MEDP, versus a peer median of 2.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | -$7.9M | -39.8% | — | 0.3% | |
| Jun 2026 | -$108.21M | -60.9% | — | 0.7% | |
| Jun 2026 | -$195.99M | -17.7% | — | 2.6% | |
FTREFortrea Holdings Inc. | Jun 2026 | -$196.5M | -26.3% | — | 7.2% |
| Jun 2026 | -$964M | -9.3% | — | 3.2% | |
| Peer median (excluding MEDP) | -$196.24M | -22.0% | — | 2.9% | |
Competitors are the stored peer set for MEDP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 461.3M | 28.27M | 245.45M | 669.44M | 497.05M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 186.43M | 253.4M | 298.4M | 296.44M | 402.08M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 52.29M | 49.98M | 63.35M | 90.5M |
| Total Current Assets | 690.91M | 333.96M | 593.83M | 1.03B | 989.62M |
| Property, Plant & Equipment (Net) | 222.71M | 248.92M | 265.39M | 252.26M | 248.87M |
| Goodwill | 662.4M | 662.4M | 662.4M | 662.4M | 662.4M |
| Intangible Assets | 41.36M | 38.01M | 35.81M | 34.37M | 33.42M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 25.13M | 48.08M | 74.44M | 100.36M | 19.22M |
| Other Non-current Assets | 17.42M | 21.13M | 24.97M | 22.25M | 21.94M |
| Total Non-current Assets | 969.02M | 1.02B | 1.06B | 1.07B | 985.85M |
| Total Assets | 1.66B | 1.35B | 1.66B | 2.1B | 1.98B |
| Account Payables | 25.68M | 33.07M | 31.87M | 32.53M | 28.14M |
| Short-term Debt | 0 | 50M | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 344.64M | 462.73M | 559.86M | 710.59M | 854.39M |
| Other Current Liabilities | 11.34M | 15.78M | 18.08M | 30.34M | 29.63M |
| Total Current Liabilities | 557.22M | 803.47M | 925.13M | 1.1B | 1.34B |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.08M | 1.07M | 2.4M | 1.8M | 1.36M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 17.75M | 22.7M | 28.22M | 42.73M | 57.66M |
| Total Non-current Liabilities | 149.79M | 162.64M | 172.75M | 170.77M | 172.65M |
| Total Liabilities | 707.01M | 966.11M | 1.1B | 1.28B | 1.52B |
| Common Stock | 360K | 309K | 308K | 306K | 284K |
| Retained Earnings | 234.98M | (359.83M) | (221.65M) | 8.17M | (459.98M) |
| Accumulated OCI | (4.85M) | (12.39M) | (10.07M) | (14.74M) | (4.91M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 952.93M | 386.39M | 558.95M | 825.55M | 459.07M |
| Total Debt | 147.24M | 208.14M | 164.49M | 149.52M | 136.85M |
| Net Debt | (314.06M) | 179.87M | (80.96M) | (519.91M) | (360.2M) |
Medpace Holdings, Inc.
NASDAQ:MEDP
Intrinsic Alpha fair value
Locked
Current Price
$646.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.